IRIS Accounts Production v22.1.4.3 09499210 Board of Directors 1.4.21 31.3.22 31.3.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure094992102021-03-31094992102022-03-31094992102021-04-012022-03-31094992102020-03-31094992102020-04-012021-03-31094992102021-03-3109499210ns16:EnglandWales2021-04-012022-03-3109499210ns15:PoundSterling2021-04-012022-03-3109499210ns11:Director12021-04-012022-03-3109499210ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3109499210ns11:SmallEntities2021-04-012022-03-3109499210ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3109499210ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3109499210ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3109499210ns11:FullAccounts2021-04-012022-03-3109499210ns6:CurrentFinancialInstruments2022-03-3109499210ns6:CurrentFinancialInstruments2021-03-3109499210ns6:ShareCapital2022-03-3109499210ns6:ShareCapital2021-03-3109499210ns6:RetainedEarningsAccumulatedLosses2022-03-3109499210ns6:RetainedEarningsAccumulatedLosses2021-03-3109499210ns11:RegisteredOffice2021-04-012022-03-3109499210ns6:PlantMachinery2021-04-012022-03-3109499210ns6:ComputerEquipment2021-04-012022-03-3109499210ns6:PlantMachinery2021-03-3109499210ns6:ComputerEquipment2021-03-3109499210ns6:PlantMachinery2022-03-3109499210ns6:ComputerEquipment2022-03-3109499210ns6:PlantMachinery2021-03-3109499210ns6:ComputerEquipment2021-03-3109499210ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3109499210ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-31
REGISTERED NUMBER: 09499210 (England and Wales)









Unaudited Financial Statements

for the Year Ended 31 March 2022

for

Russell Cardiology Limited

Russell Cardiology Limited (Registered number: 09499210)






Contents of the Financial Statements
for the Year Ended 31 March 2022




Page

Balance Sheet 1

Notes to the Financial Statements 2


Russell Cardiology Limited (Registered number: 09499210)

Balance Sheet
31 March 2022

31.3.22 31.3.21
Notes £    £   
FIXED ASSETS
Tangible assets 4 53 63

CURRENT ASSETS
Debtors 5 3,441 958
Cash at bank 53,322 51,829
56,763 52,787
CREDITORS
Amounts falling due within one year 6 (7,973 ) (7,068 )
NET CURRENT ASSETS 48,790 45,719
TOTAL ASSETS LESS CURRENT LIABILITIES 48,843 45,782

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 48,833 45,772
SHAREHOLDERS' FUNDS 48,843 45,782

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 August 2022 and were signed on its behalf by:





Dr S J Russell - Director


Russell Cardiology Limited (Registered number: 09499210)

Notes to the Financial Statements
for the Year Ended 31 March 2022

1. STATUTORY INFORMATION

Russell Cardiology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09499210

Registered office: Westminster House
10 Westminster Road
Macclesfield
Cheshire
SK10 1BX

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable.

When the outcome of a transaction can be estimated reliably, turnover from services is recognised by reference to the stage of completion at the balance sheet date. Stage of completion is measured by reference to finalisation of work completed.

Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 15% on reducing balance
Computer equipment - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
Equipment equipment Totals
£    £    £   
COST
At 1 April 2021
and 31 March 2022 166 1,233 1,399
DEPRECIATION
At 1 April 2021 103 1,233 1,336
Charge for year 10 - 10
At 31 March 2022 113 1,233 1,346
NET BOOK VALUE
At 31 March 2022 53 - 53
At 31 March 2021 63 - 63

Russell Cardiology Limited (Registered number: 09499210)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.22 31.3.21
£    £   
Trade debtors 3,441 958

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.22 31.3.21
£    £   
Taxation and social security 6,162 5,918
Other creditors 1,811 1,150
7,973 7,068